Kansas City, Mo. – Jurox Pty Ltd, an Australian veterinary pharmaceutical company, announced that it has selected Kansas City, Mo., in the KC Animal Health Corridor, for its U.S. headquarters.
“Kansas City is the obvious best location to launch Jurox’s U.S. operations,” said John O’Brien, managing director for Jurox. “The region offers a broad portfolio of animal health companies, a first-rate talent pool, and a superior transportation network that connects us to clientele around the country and globe. Kansas City’s reputation and resources in animal sciences provides advantages you can’t find elsewhere.”
Jurox evaluated multiple locations across the country for its U.S. headquarters.
Bob Marcusse, president and CEO of the Kansas City Area Development Council, said, “The KC Animal Health Corridor’s high concentration of animal health entities paired with accessibility to distribution and service providers makes the Kansas City area an ideal location for Jurox to grow their presence and succeed in the U.S.”
Jurox will create 13 jobs based in Kansas City and an additional 31 positions located throughout the U.S.
The company selected the KC region due to its concentration of skilled workforce, intellectual capital and accessibility to service providers
“I’m thrilled that Jurox, an animal health company with an international profile, will be putting down roots in Kansas City,” said Mayor Sly James. “This announcement is further proof that our economy is growing in all the right ways and with an eye towards high growth industries of the future.”
The Kansas City Area Development Council was honored to work with many regional partners in attracting Jurox to the KC region including the City of Kansas City, Missouri; Economic Development Corporation of Kansas City, Missouri ; the State of Missouri – Office of Governor Jay Nixon; Missouri Department of Economic Development; Missouri Partnership; Greater Kansas City Chamber of Commerce; Office of Congressman Emmanuel Cleaver; KCP&L; Office of Congressman Sam Graves; CBIZ Accounting, Tax & Advisory Services, LLC; Polsinelli PC; Bank of Kansas City; Aerotek, Inc.; Missouri Gas Energy; Metro Park Warehouses and KC SmartPort.
About Jurox. Jurox is an established family owned veterinary pharmaceutical company that manufactures and markets in excess of 120 proprietary animal health products in over 20 countries. With global headquarters in the Hunter Valley Australia, Jurox maintains commercial operations in New Zealand and the United Kingdom and has recently established their U.S. headquarters in Kansas City, Missouri.
Jurox invests 15% of sales in research and development, much of which is carried out on the group’s own research stations. The Company is GMP certified under MRA, US FDA inspected and NATA recognized for compliance with the OECD Principles of Good Laboratory Practice and ISO17025 Laboratory Accredited.
Jurox’s mission is to deliver uncompromised quality driven by innovation, adding value for customers willing to work with a long-term partner committed to supporting their business’ needs. Jurox aims to provide veterinarians, pet owners and livestock producers with innovative and practical solutions to improve the well-being and sustainability of Animal Health.
For more information, visit jurox.com.au.
About the KC Animal Health Corridor
The KC Animal Health Corridor accounts for nearly one third of the global animal health industry. The Corridor, anchored by Manhattan, Kan., and Columbia, Mo., is home to more than 300 animal health companies, representing the largest concentration in the world. For more information, visit KCanimalhealth.com.